Dr. Vince Clinical Research Expands Campus, Invests in People, Infrastructure, and Innovation
PorAinvest
jueves, 24 de julio de 2025, 2:06 pm ET1 min de lectura
VNCE--
The new building, which will be celebrated with an employee open house, is home to DVCR's finance, human resources, marketing, and volunteer recruitment teams. Strategically located on the existing 75,000-square-foot campus, the building mirrors the headquarters' architectural style, ensuring a seamless and unified environment for employees and visitors alike [1].
"DVCR first opened its doors in late 2022, and in less than three years, we have grown to approximately 250 employees globally," said Dr. Brad Vince, CEO and Chief Medical Officer at DVCR. "That growth—combined with being awarded over 100 clinical trials across Phases I through IV—is a true testament to the dedication of our team and the trust our clients place in us" [1].
The project, which received unanimous approval from the Overland Park Planning Commission in March 2024, broke ground in June 2025 and was completed in under a year, demonstrating DVCR's efficient execution and momentum as a CRO leader [1].
References:
[1] https://www.businesswire.com/news/home/20250724651877/en/Campus-Expansion-Marks-Dr.-Vince-Clinical-Researchs-Investment-in-People-Infrastructure-and-Innovation
Dr. Vince Clinical Research, a fast-growing contract research organization, has opened a new 5,000-square-foot administrative building on its flagship campus in Overland Park, Kansas. The expansion reflects the company's investment in people, infrastructure, and innovation. With approximately 250 employees globally and over 100 clinical trials across Phases I-IV, Dr. Vince Clinical Research continues to grow and attract new clients and talent in the clinical research industry.
Overland Park, Kan.--Dr. Vince Clinical Research (DVCR), a leading contract research organization (CRO), has marked a significant milestone with the official opening of its new 5,000-square-foot administrative building on its flagship campus in Overland Park, Kansas. The expansion underscores DVCR's commitment to operational excellence, people, and infrastructure, as it continues to grow and innovate in the clinical research industry [1].The new building, which will be celebrated with an employee open house, is home to DVCR's finance, human resources, marketing, and volunteer recruitment teams. Strategically located on the existing 75,000-square-foot campus, the building mirrors the headquarters' architectural style, ensuring a seamless and unified environment for employees and visitors alike [1].
"DVCR first opened its doors in late 2022, and in less than three years, we have grown to approximately 250 employees globally," said Dr. Brad Vince, CEO and Chief Medical Officer at DVCR. "That growth—combined with being awarded over 100 clinical trials across Phases I through IV—is a true testament to the dedication of our team and the trust our clients place in us" [1].
The project, which received unanimous approval from the Overland Park Planning Commission in March 2024, broke ground in June 2025 and was completed in under a year, demonstrating DVCR's efficient execution and momentum as a CRO leader [1].
References:
[1] https://www.businesswire.com/news/home/20250724651877/en/Campus-Expansion-Marks-Dr.-Vince-Clinical-Researchs-Investment-in-People-Infrastructure-and-Innovation

Divulgación editorial y transparencia de la IA: Ainvest News utiliza tecnología avanzada de Modelos de Lenguaje Largo (LLM) para sintetizar y analizar datos de mercado en tiempo real. Para garantizar los más altos estándares de integridad, cada artículo se somete a un riguroso proceso de verificación con participación humana.
Mientras la IA asiste en el procesamiento de datos y la redacción inicial, un miembro editorial profesional de Ainvest revisa, verifica y aprueba de forma independiente todo el contenido para garantizar su precisión y cumplimiento con los estándares editoriales de Ainvest Fintech Inc. Esta supervisión humana está diseñada para mitigar las alucinaciones de la IA y garantizar el contexto financiero.
Advertencia sobre inversiones: Este contenido se proporciona únicamente con fines informativos y no constituye asesoramiento profesional de inversión, legal o financiero. Los mercados conllevan riesgos inherentes. Se recomienda a los usuarios que realicen una investigación independiente o consulten a un asesor financiero certificado antes de tomar cualquier decisión. Ainvest Fintech Inc. se exime de toda responsabilidad por las acciones tomadas con base en esta información. ¿Encontró un error? Reportar un problema

Comentarios
Aún no hay comentarios